Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression, and Racial/Ethnic Disparities.

Cunningham WE, Ford CL, Kinsler JJ, Seiden D, Andrews L, Nakazono T, Bell DS.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):290-298. doi: 10.1097/QAI.0000000000001385.

PMID:
28368951
3.

Medicaid Managed Care and Racial Disparities in AIDS Treatment.

Guwani JM, Weech-Maldonado R.

Health Care Financ Rev. 2004 Winter;26(2):119-132.

4.

Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.

Adedinsewo DA, Wei SC, Robertson M, Rose C, Johnson CH, Dombrowski J, Skarbinski J.

AIDS Patient Care STDS. 2014 Dec;28(12):613-21. doi: 10.1089/apc.2014.0194.

5.

The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS.

Abara WE, Smith L, Zhang S, Fairchild AJ, Heiman HJ, Rust G.

Am J Public Health. 2014 Nov;104(11):e135-41. doi: 10.2105/AJPH.2014.302227. Epub 2014 Sep 11.

6.

Hospitalization rates of people living with HIV in the United States, 2009.

Bachhuber MA, Southern WN.

Public Health Rep. 2014 Mar-Apr;129(2):178-86.

7.

HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

Des Jarlais DC, McCarty D, Vega WA, Bramson H.

Am Psychol. 2013 May-Jun;68(4):274-85. doi: 10.1037/a0032745.

8.

Community poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004.

Trepka MJ, Niyonsenga T, Maddox L, Lieb S, Lutfi K, Pavlova-McCalla E.

Am J Public Health. 2013 Apr;103(4):717-26. doi: 10.2105/AJPH.2012.300930. Epub 2013 Feb 14.

9.

Predictors of highly active antiretroviral therapy utilization for behaviorally HIV-1-infected youth: impact of adult versus pediatric clinical care site.

Agwu AL, Siberry GK, Ellen J, Fleishman JA, Rutstein R, Gaur AH, Korthuis PT, Warford R, Spector SA, Gebo KA.

J Adolesc Health. 2012 May;50(5):471-7. doi: 10.1016/j.jadohealth.2011.09.001. Epub 2011 Nov 4.

11.

Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008).

Fleishman JA, Yehia BR, Moore RD, Gebo KA, Agwu AL; HIV Research Network.

Med Care. 2012 May;50(5):419-27. doi: 10.1097/MLR.0b013e31824e3356.

12.

A cross-sectional study of barriers to personal health record use among patients attending a safety-net clinic.

Hilton JF, Barkoff L, Chang O, Halperin L, Ratanawongsa N, Sarkar U, Leykin Y, Muñoz RF, Thom DH, Kahn JS.

PLoS One. 2012;7(2):e31888. doi: 10.1371/journal.pone.0031888. Epub 2012 Feb 20.

13.

Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system.

Ohl M, Lund B, Belperio PS, Goetz MB, Rimland D, Richardson K, Justice A, Perencevich E, Vaughan-Sarrazin M.

AIDS Behav. 2013 Jan;17(1):250-9. doi: 10.1007/s10461-011-0107-8.

14.

Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART.

Cocohoba JM, Althoff KN, Godfrey R, Palella FJ, Greenblatt RM.

AIDS Care. 2012;24(1):20-9. doi: 10.1080/09540121.2011.592814. Epub 2011 Jul 6.

15.

Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network.

Agwu AL, Fleishman JA, Korthuis PT, Siberry GK, Ellen JM, Gaur AH, Rutstein R, Gebo KA; HIV Research Network.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):100-7. doi: 10.1097/QAI.0b013e31822327df.

16.

The adoption of mental health drugs on state AIDS drug assistance program formularies.

Martin EG, Barry CL.

Am J Public Health. 2011 Jun;101(6):1103-9. doi: 10.2105/AJPH.2010.300100. Epub 2011 Apr 14.

17.

Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.

Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E.

J Infect Dis. 2011 Feb 15;203(4):442-51. doi: 10.1093/infdis/jiq085. Epub 2011 Jan 18.

18.

The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women.

Yi T, Cocohoba J, Cohen M, Anastos K, DeHovitz JA, Kono N, Hanna DB, Hessol NA.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):253-62. doi: 10.1097/QAI.0b013e31820a9d04.

19.
20.

Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.

Simard EP, Pfeiffer RM, Engels EA.

Cancer. 2011 Mar 1;117(5):1089-96. doi: 10.1002/cncr.25547. Epub 2010 Oct 19.

Supplemental Content

Support Center